PYOTT DAVID E I 4
4 · ALNYLAM PHARMACEUTICALS, INC. · Filed May 12, 2025
Insider Transaction Report
Form 4
PYOTT DAVID E I
Director
Transactions
- Award
Stock Option (right to buy)
2025-05-08+1,558→ 1,558 totalExercise: $258.35From: 2026-05-08Exp: 2035-05-08→ Common Stock (1,558 underlying) - Award
Common Stock
2025-05-08+775→ 911 total
Holdings
- 27,900(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]These shares are represented by restricted stock units (RSUs) granted under the Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.
- [F2]The shares of ALNY common stock were purchased by the David E I Pyott Trust, of which the reporting person is trustee.
- [F3]The stock option vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.